Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for authorization to use the vaccine in children in that age range in the United States, Europe and elsewhere as soon as possible.
The companies said the vaccine generated an immune response in the 5-to-11 year olds in their Phase II/III clinical trial that matched what they had previously observed in 16-to-25 year olds. The safety profile was also generally comparable to the older age group, they said.
"Since July, pediatric cases of COVID-19 have risen by about 240 percent in the U.S. – underscoring the public health need for vaccination," Pfizer Chief Executive Albert Bourla said in a news release.
"These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency."
Top U.S. health officials believe regulators could make a decision on whether the shot is safe and effective in younger children within three weeks of the companies submitting a request for authorization, two sources told Reuters earlier this month.
COVID-19 hospitalizations and deaths have surged in the United States in recent months due to the highly contagious Delta variant. Pediatric cases are also up, particularly as children under 12 are all unvaccinated, but there is no indication that, beyond being more transmissive, the Delta virus is more dangerous in kids.
A rapid authorization could help mitigate a potential surge of cases in the fall, especially with schools already open nationwide.
The companies' vaccine, called Comirnaty, is already authorized for use in children as young as 12 in many countries, including the United States. The vaccine was originally authorized for emerenecy use in people 16 or older in the United States in December 2020 and received full U.S. approval in that age group last month.
The 5-to-11 year olds were given two shots of a 10-microgram dose of the vaccine, one-third the dose size that has been given to people 12 and older. The companies expect data on how well the vaccine works in children 2-to-5 years of age and children 6 months-to-2 years of age as soon as the fourth quarter of this year.
Unlike the larger clinical trial the drugmakers previously conducted in adults, the 2,268 participant pediatric trial was not primarily designed to measure the vaccine's efficacy by comparing the number of COVID-19 cases in vaccine recipients to those who received a placebo.
Instead, the trial compares the amount of neutralizing antibodies induced by the vaccine in the children to the response of older recipients in the adult trial.
A Pfizer spokesperson said the companies may later disclose vaccine efficacy from the trial but there had not been enough cases of COVID-19 yet among the participants to make that determination.
The vaccine was around 95 percent effective in the adult clinical trial, but Pfizer has said that immunity wanes some months after the second dose. U.S. regulators are expected to authorize a third, booster dose of the vaccine for older and high-risk Americans early this week.
The companies said the vaccine was well-tolerated, with side effects generally comparable to those observed in participants 16 to 25 years of age.
Both the Pfizer and Moderna vaccines have been linked by regulators to rare cases of heart inflammation in adolescents and young adults, particularly young men. Pfizer said they did not see any instances of heart inflammation in the trial participants.
Reuters
Mon Sep 20 2021
A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic
Protes pro-Palestin di Israel sempena 76 tahun Nakba
Kira-kira 3,000 orang berarak di sepanjang laluan berhampiran lebuhraya utama - dalam apa yang digelar sebagai return march, yang telah diadakan setiap tahun sejak 27 tahun lalu.
AWANI Pagi: Hari Belia - Pemimpin belia wanita dalam pembuatan keputusan
Pemimpin belia wanita bukan sahaja membawa suara wanita, tetapi juga menyuarakan keperluan pelbagai kumpulan belia.
Bersempena Hari Belia 2024, ikuti temu bual program #AWANIPagi yang membincangkan peranan penting pemimpin belia wanita dalam membentuk masa depan negara.
#AWANInews #AWANIPagi
Bersempena Hari Belia 2024, ikuti temu bual program #AWANIPagi yang membincangkan peranan penting pemimpin belia wanita dalam membentuk masa depan negara.
#AWANInews #AWANIPagi
Kemboja rai ulang tahun keputeraan ke-71 raja dengan persembahan bunga api
Persembahan bunga api yang memukau itu berlangsung kira-kira 20 minit dan letupan warna-warninya menarik perhatian orang ramai.
Lelaki dikejar polis selepas cuba merampas sebuah treler
Lelaki itu dibawa ke hospital selepas ditembak di dada semasa proses tangkapan dilakukan.
Pemindahan pokok tidak disaran kerana ia memudaratkan sistem ekologi - Pakar
Tambahnya lagi, pemindahan untuk satu pokok juga bukanlah sesuatu perkara yang murah dan ia sekali gus memerlukan satu teknikaliti yang sangat tinggi.
Kerajaan cadang Akta Pembangunan Hartanah bagi Semenanjung Malaysia - Nga
Beliau berkata, inilah masanya untuk kerajaan mempertimbang akta yang lebih komprehensif, telus dan bertanggungjawab.
Sindiket dadah tumpas, lelaki ditahan bersama 20 bungkus heroin
Suspek direman selama enam hari bermula Selasa hingga 19 Mei bagi membantu siasatan.
Strategi Singapura sesuai diadaptasi di Malaysia untuk pulihara keadaan pokok - Pakar
Usaha konservasi pokok warisan menerusi Heritage Tree Scheme yang dilaksanakan Lembaga Taman Negara Singapura (NParks) boleh dijadikan contoh.
Lelaki dikejar polis selepas cuba merampas sebuah lori
Seorang suspek perampas lori telah ditahan pada malam isnin selepas dikejar polis dalam keadaan berbahaya melalui beberapa jalan di lima, ibu negara peru.
Kamera keselamatan di perbandaran ate, timur lima, menunjukkan lelaki itu melarikan diri dengan panik melalui beberapa jalan di daerah itu, sehingga berlanggar dengan kenderan peronda polis dan bergerak dalam keadaan bersimpang siur tanpa mengendahkan arahan pegawai polis.
Kamera keselamatan di perbandaran ate, timur lima, menunjukkan lelaki itu melarikan diri dengan panik melalui beberapa jalan di daerah itu, sehingga berlanggar dengan kenderan peronda polis dan bergerak dalam keadaan bersimpang siur tanpa mengendahkan arahan pegawai polis.
Peralihan teraju kepimpinan Singapura malam ini
Upacara angkat sumpah perdana menteri keempat Singapura itu akan berlangsung pada 8 malam ini di Istana.
Kerajaan jamin sediakan rawatan kesan sampingan vaksin COVID-19 termasuk AstraZeneca - Dzulkefly
Kerajaan memberi jaminan akan menyediakan rawatan susulan bagi penerima vaksin COVID-19 termasuk AstraZeneca yang terbukti mengalami kesan sampingan.
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
Isu tunggakan cetakan MyKid bakal selesai Julai ini - JPN
Isu cetakan MyKid yang tertunggak akibat masalah perolehan bekalan mikrocip semasa pandemik COVID-19 lalu dijangka dapat diselesaikan pada Julai ini secara berperingkat di seluruh negara.
Program Jana Wibawa dilaksana selepas dapat persetujuan Jemaah Menteri - Saksi
Mahkamah Sesyen di sini hari ini diberitahu bahawa cadangan mengenai Jana Wibawa telah dibawa ke mesyuarat untuk pertimbangan sebelum Jemaah Menteri memutuskan supaya program itu diteruskan pada 2020.
Kelaparan akut jejaskan 281.6 juta orang tahun lepas - PBB
Tahap bahaya kelaparan akut menjejaskan 281.6 juta orang tahun lepas, tahun kelima berturut-turut bahawa ketakjaminan makanan semakin memburuk.
Hamilton optimis kedudukan lebih baik di GP China
Lewis Hamilton melihat potensi kedudukan yang lebih baik dalam saingan Grand Prix yang kembali ke China buat pertama kali dalam tempoh lima tahun, hujung minggu ini.
'Selfish!' - Fasha Sandha sedih raya di Perlis tak jadi gara-gara dijangkiti COVID-19
Fasha berkata dia mula melakukan pemeriksaan COVID-19 selepas berasa tidak sihat badan dan mengalami bersin tidak henti sejak Raya pertama.
Kes COVID-19 catat penurunan ketara pada ME 14/2024 - KKM
Jumlah kes COVID-19 menurun 97.1 peratus kepada 493 kes pada Minggu Epidemiologi ke-14 (ME 14/2024) iaitu bagi tempoh 31 Mac hingga 6 April lepas berbanding 17,256 kes pada ME 1/2024.
China jadikan pengalaman pencegahan COVID-19 untuk hadapi pandemik masa depan
China akan menjadikan pengalaman dalam pencegahan dan kawalan COVID-19 untuk membuat persediaan yang lebih proaktif untuk menghadapi pandemik masa depan seperti "Penyakit X".
Negara berdepan ketirisan subsidi diesel serius - Amir Hamzah
Negara kini sedang berdepan isu ketirisan subsidi diesel yang serius dan wujud kemungkinan terdapat pihak yang tidak layak masih menikmati subsidi itu, kata Menteri Kewangan II Datuk Seri Amir Hamzah.